ケーススタディ：がん免疫治療の課題解決へ向けて

IMMUNO-ONCOLOGY CASE STUDY

Genedata Profiler™ enables translational and clinical researchers to overcome major clinical trial challenges. In a recent immuno-oncology (I-O) clinical trial, scientists used Genedata Profiler to analyze data from 45 patients and identify predictive biomarkers by integrating genomic, transcriptomic, and metabolomic data, and immunohistochemistry (IHC) tumor profiles. The biomarkers enable further definition of tumor subtypes and thus identification and selection of patient profiles that will benefit from the I-O therapy, consequently improving the outcome of the treatment.